anti-beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) Antibodies

B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. Additionally we are shipping B4GALNT2 Proteins (6) and B4GALNT2 Kits (3) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
B4GALNT2 124872 Q8NHY0
Anti-Mouse B4GALNT2 B4GALNT2 14422 Q09199
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-B4GALNT2 Antibodies at antibodies-online.com

Showing 10 out of 28 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Delivery Price Details
Human Rabbit Un-conjugated WB Host: Rabbit Target Name: B4GALNT2 Sample Type: Jurkat Whole Cell lysates Antibody Dilution: 1.0ug/ml 100 μL 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated ELISA, WB Western blot analysis of B4GALNT2 using HeLa whole cell lysates 100 μL 11 to 12 Days
$390.77
Details
Human Rabbit Un-conjugated WB 100 μL 11 to 14 Days
$551.83
Details
Human Rabbit Un-conjugated ICC, IHC, WB Figure. Western Blot; Sample: Recombinant b4GALNT2, Human. Figure.DAB staining on IHC-P. Samples: Human Tissue 100 μg 13 to 16 Days
$350.00
Details
Human Rabbit Un-conjugated IF/ICC, IHC, IP, WB Western blot analysis of recombinant Human b4GALNT2. IHC-P analysis of Human Tissue, with DAB staining. 100 μg 31 to 36 Days
$341.12
Details
Human Rabbit Un-conjugated IHC (p) Immunohistochemical staining of human prostate with B4GALNT2 polyclonal antibody  shows strong cytoplasmic positivity in glandular cells. 100 μL 11 to 12 Days
$577.33
Details
Human Rabbit Un-conjugated ELISA, IHC, WB   100 μg 13 to 16 Days
$380.00
Details
Human Rabbit Biotin ELISA   100 μg 11 to 16 Days
$469.05
Details
Human Rabbit FITC ELISA   100 μg 11 to 16 Days
$469.05
Details
Human Rabbit HRP ELISA   100 μg 11 to 16 Days
$469.05
Details

Top referenced anti-B4GALNT2 Antibodies

  1. Human Polyclonal B4GALNT2 Primary Antibody for IHC, IHC (fro) - ABIN4282651 : Chicoine, Rodino-Klapac, Shao, Xu, Bremer, Camboni, Golden, Montgomery, Shontz, Heller, Griffin, Lewis, Coley, Walker, Clark, Sahenk, Mendell, Martin: Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates. in Molecular therapy : the journal of the American Society of Gene Therapy 2014 (PubMed)
    Show all 4 Pubmed References

More Antibodies against B4GALNT2 Interaction Partners

Human beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) interaction partners

  1. B4GALNT2 overexpression prevented the infection of every avian influenza virus strain tested, including the H5, H9, and H7 subtypes, which have previously caused disease in humans.

  2. In normal colon samples a significant relationship between sLe(x) expression and the ratio between FUT6/B4GALNT2 activities exists, demonstrating for the first time a role for B4GALNT2 in sLe(x) inhibition in vivo.

  3. These experiments demonstrate successful transduction of rhesus macaque muscle with rAAVrh74.MCK.GALGT2 after vascular delivery and induction of molecular changes thought to be therapeutic in several forms of muscular dystrophy.

  4. molecular cloning; cDNA predicts a 566 aa protein showing 66.6% and 39% identity with mouse CT beta4GalNAc-T and human GM2/GD2 synthase

  5. A putative CpG island encompassing the promoter and exon 1 regions in the human Sd(a) beta4GalNAcT-II gene was identified.

  6. Epigenetic changes in a group of glycosyltransferases including B4GALNT2 and ST3GAL6 represent a malignant phenotype of gastric cancer caused by silencing of the activity of these enzymes

Mouse (Murine) beta-1,4-N-Acetyl-Galactosaminyl Transferase 2 (B4GALNT2) interaction partners

  1. B4galnt2 displays an interesting spatial allelic distribution in Western Europe, likely due to the recent action of natural selection.

  2. Overexpression of Galgt2 failed to inhibit skeletal muscle pathology in dystroglycan-deficient muscles

  3. These data support a critical role for B4galnt2 in gastrointestinal infections

  4. Galgt2 is required for postsynaptic expression of the CT carbohydrate at the neuromuscular junction.

  5. We describe changes that result from overexpression of Galgt2, a normally synaptic muscle glycosyltransferase that can modify alpha dystroglycan and inhibit the development of muscular dystrophy when it is overexpressed.

  6. Study describes detailed characterization of mouse gastrointestinal bacterial communities in 7 distinct locations from the duodenum to the colon and provide evidence for a significant effect of B4galnt2 expression on intestinal bacterial populations.

  7. Data suggest that B4GALNT2 and Sd(a) antigen are essential for embryo implantation.

  8. Expression of B4galnt2 in pregnant mice is regulated by progesterone. The naturally occurring up-regulation of B4galnt2 during pregnancy contributes to normal embryo implantation.

  9. we show that overexpression of the cytotoxic T cell (CT) GalNAc transferase (Galgt2) is effective in inhibiting the development of muscle pathology in the dy(W) mouse model of MDC1A

  10. These experiments demonstrate that Galgt2 can control growth by modulating the expression of myostatin and myostatin inhibitors during particular periods of muscle development.

  11. low VWF levels may represent a fitness cost that is offset by a yet unknown benefit of the B4galnt2 tissue-specific switch.

  12. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.

  13. Galgt2 has therapeutic effects in three distinct forms of muscular dystrophy

B4GALNT2 Antigen Profile

Protein Summary

B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003

Gene names and symbols associated with B4GALNT2

  • beta-1,4-N-acetyl-galactosaminyltransferase 2 (B4GALNT2) antibody
  • beta-1,4-N-acetyl-galactosaminyl transferase 2 (B4galnt2) antibody
  • AI593864 antibody
  • B4GALT antibody
  • Dlb-1 antibody
  • Dlb1 antibody
  • Galg2 antibody
  • Galgt2 antibody
  • Ggm3 antibody
  • Igf2bp1 antibody

Protein level used designations for B4GALNT2

UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase , UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase , beta 1,4 N-acetylgalactosaminyltransferase/betal,4 GalNAcT/Sda-GalNAcT , beta-1,4 N-acetylgalactosaminyltransferase 2 , beta-4-N-acetylgalactosaminyltransferase , sd(a) beta-1,4-GalNAc transferase , sda beta-1,4-GalNAc transferase , CT-Gal NAc transferase , N-acetylgalactosaminyltransferase , UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosyl-N-acetylglucosaminylpolypeptide-beta-1, 4-N-acetylgalactosaminyltransferase , dolichos lectin binding 1

GENE ID SPECIES
124872 Homo sapiens
14422 Mus musculus
Selected quality suppliers for anti-B4GALNT2 (B4GALNT2) Antibodies
Did you look for something else?